Moxifloxacin for tuberculosis

被引:5
作者
Mendel, Carl [1 ]
Springsklee, Martin [2 ]
机构
[1] Global Alliance TB Drug Dev, New York, NY USA
[2] Global Med Affairs, Head Therapy Areas Antiinfect, Wuppertal, Germany
关键词
RESISTANCE;
D O I
10.1016/S1473-3099(11)70351-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:176 / 177
页数:2
相关论文
共 8 条
  • [1] Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics
    Abu-Raddad, Laith J.
    Sabatelli, Lorenzo
    Achterberg, Jerusha T.
    Sugimoto, Jonathan D.
    Longini, Ira M., Jr.
    Dye, Christopher
    Halloran, M. Elizabeth
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) : 13980 - 13985
  • [2] Rational use of moxifloxacin for tuberculosis treatment
    Cox, Helen
    Ford, Nathan
    Keshavjee, Salmaan
    McDermid, Cheryl
    von Schoen-Angerer, Tido
    Mitnick, Carole
    Goemaere, Eric
    [J]. LANCET INFECTIOUS DISEASES, 2011, 11 (04) : 259 - 260
  • [3] Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits
    Etienne, M
    Croisier, D
    Charles, PE
    Lequeu, C
    Piroth, L
    Portier, H
    Drlica, K
    Chavanet, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (08) : 1472 - 1475
  • [4] The global problem of multidrug-resistant tuberculosis - The genie is out of the bottle
    Horsburgh, CR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (19): : 2575 - 2576
  • [5] Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis:: Correlation with ofloxacin susceptibility
    Kam, KM
    Yip, CW
    Cheung, TL
    Tang, HS
    Leung, OC
    Chan, MY
    [J]. MICROBIAL DRUG RESISTANCE, 2006, 12 (01) : 7 - 11
  • [6] Prospects for advancing tuberculosis control efforts through novel therapies
    Salomon, Joshua A.
    Lloyd-Smith, James O.
    Getz, Wayne M.
    Resch, Stephen
    Sanchez, Maria S.
    Porco, Travis C.
    Borgdorff, Martien W.
    [J]. PLOS MEDICINE, 2006, 3 (08) : 1302 - 1309
  • [7] Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB
    Von Groll, Andrea
    Martin, Anandi
    Jureen, Pontus
    Hoffner, Sven
    Vandamme, Peter
    Portaels, Francoise
    Palomino, Juan Carlos
    da Silva, Pedro Almeida
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4498 - 4500
  • [8] THE EFFECT OF DIRECTLY OBSERVED THERAPY ON THE RATES OF DRUG-RESISTANCE AND RELAPSE IN TUBERCULOSIS
    WEIS, SE
    SLOCUM, PC
    BLAIS, FX
    KING, B
    NUNN, M
    MATNEY, GB
    GOMEZ, E
    FORESMAN, BH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) : 1179 - 1184